Skip Global navigation and goto content

It's a New Day in Public Health.

The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.

Skip MegaMenu and goto content
Megamenu requires javascript to be enabled in your browser.

Sign up for the weekly
Florida Flu Review
and RSV Review email.

* Denotes required field


Respiratory Syncytial Virus

Florida Health

Disease Control

Florida RSV Review

Activity Summary

Week 49 (December 1 - 7, 2024)

Emergency room visits
Decreased

RSV postivity rate
Decreased

RSV admissions
Decreased

Weekly Outbreaks
0

Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. Young children and older adults, especially those with certain underlying health conditions, are at higher risk for severe illness from RSV.

Individual cases of RSV are not reportable in Florida. All outbreaks of RSV are reportable. The Florida Department of Health will continue to make updates on the trends presented in this report as needed.

Season
Florida’s RSV season is longer than the rest of the nation and has distinct regional patterns. For this reason, the state isbroken up into five RSV regions, each with their own RSVseason. The Florida Department of Health established regional RSV seasons based on activity thresholds providedby the Centers for Disease Control and Prevention.

Florida RSV Regions

NorthwestOctober-April
NorthSeptember-March
CentralAugust-March
SoutheastJanuary-December
SouthwestSeptember-April

Surveillance and investigation
Surveillance is conducted to support clinical decision-making for prophylaxis of premature infants. The determination of unique seasonal and geographic trends in RSV activity in Florida has important implications for prescribing patterns for initiating prophylaxis to children at high risk for complications from RSV infection. The American Academy of Pediatrics currently recommends pre-approval for prophylactic treatment be made based on state surveillance data.

In 2023, two vaccines (Arexvy and Abrysvo) and a monoclonal antibody (nirsevimab) were approved for the prevention of RSV related illness. For more information about these products, refer to the links below.


Week 49, 2024 Counties currently in Season: Northwest, North, Central, Southwest, Southeast  County RSV activity: Increasing: BAKER, BAY, BRADFORD, BREVARD, CALHOUN, CITRUS, CLAY, COLUMBIA, DESOTO, FRANKLIN, GADSDEN, GULF, JACKSON, JEFFERSON, LAFAYETTE, LEON, LIBERTY, PUTNAM, ST JOHNS, SUMTER, UNION, VOLUSIA, WAKULLA, WALTON, WASHINGTON  Decreasing: ALACHUA, BROWARD, CHARLOTTE, COLLIER, DIXIE, FLAGLER, GILCHRIST, GLADES, HAMILTON, HARDEE, HENDRY, HIGHLANDS, HILLSBOROUGH, HOLMES, LAKE, MARTIN, MIAMI-DADE, MONROE, OKEECHOBEE, ORANGE, PALM BEACH, PASCO, PINELLAS, SANTA ROSA, ST LUCIE, SUWANNEE, TAYLOR  No change: DUVAL, ESCAMBIA, HERNANDO, INDIAN RIVER, LEE, LEVY, MADISON, MANATEE, MARION, NASSAU, OKALOOSA, OSCEOLA, POLK, SARASOTA, SEMINOLE

To learn more about RSV in Florida, please visit FloridaHealth.gov/RSV.